In a strategic move to bolster its healthcare platform, Earth Science Tech, Inc. (OTC: ETST) has acquired Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. The acquisition, announced today, is expected to integrate Zoolzy’s operations into ETST’s supply chain, providing its compounding pharmacies with direct access to competitive wholesale pricing on APIs. This could significantly improve profit margins across ETST’s healthcare subsidiaries.
Zoolzy, based in Doral, Florida, operates from a 3,684-square-foot facility and specializes in the distribution of APIs and finished pharmaceuticals. By bringing this distributor in-house, ETST aims to streamline procurement processes, reduce reliance on third-party suppliers, and ensure a more consistent supply of essential ingredients. This vertical integration is a key component of ETST’s strategy to build a fully integrated healthcare platform that spans from compounding pharmacy operations to telemedicine and direct-to-patient fulfillment.
Beyond cost savings, the acquisition opens new avenues for growth, particularly in the veterinary sector. ETST plans to leverage Zoolzy’s established supplier networks to procure novel APIs necessary for custom compounding, which will allow the company to develop unique, flavored, and easy-to-administer veterinary therapeutics. This initiative is being led by members of ETST’s management team who have experience and established connections in the exotic wildlife space, positioning the company to tap into a niche but growing market for specialized animal health products.
The expansion into veterinary medicine is a logical extension of ETST’s existing capabilities. With the ability to compound medications, the company can create tailored formulations for animals, addressing a need for more palatable and convenient dosing options. This move not only diversifies ETST’s revenue streams but also capitalizes on the increasing demand for high-quality veterinary care.
ETST’s acquisition of Zoolzy is a testament to its commitment to vertical integration and operational efficiency. By owning its supply chain, the company can better control costs, ensure quality, and respond more agilely to market demands. This strategic acquisition is expected to have immediate positive effects on ETST’s bottom line and long-term growth prospects.
Investors and industry watchers will be keen to see how ETST leverages this acquisition to enhance its competitive position. The company’s focus on compounding pharmacy and telemedicine, combined with the new supply chain capabilities, positions it well to capitalize on the growing trend toward personalized medicine and integrated healthcare services.
For more information on Earth Science Tech, Inc., visit the company’s newsroom at https://ibn.fm/ETST.
